Agencies should show a sharper edge and say more clearly what they are good at.1

1 Bathen D. 2016

co.patient's focus is on patient relations.

Our team

co.patient has an interdisciplinary team of doctors, healthcare scientists, marketing strategists and communication experts who have many years of experience in the fields of patient relations, patient communication and patient engagement – all with a genuine appreciation of the patients.

Dr. Holger Müller
Co-Managing Director

Dr. Julia A. Gaebler
Managing Director

Dr. Susanne Neureuther-Keckeis

Hannes Fuß

Peter Jungblut

Dr. Stefan Baumanns

Dr. Juliane Schreier

Dr. Alexander Boreham

Dr. Michael Wördehoff

Dr. med. vet. Anne Beiersdorf

Dr. Christiane Ring

Dr. Linda Sawade

Dr. Mira Meyer-Ács

Marie Simon, B. A.

Dr. med. Juliane Scholz

Dr. Philipp Bauknecht

Lisa Kramer, M. Sc.

Anne Hofmann, M. Sc.

Dr. Bastian Gaus

Lisa Kiesel, Pharmacist

Dr. Kai Lucaßen

Leonie Hirt, M. Sc.

Laura Loke, B. Sc.

Hans Hirsch, B. A.

Julian Radlinger, M. Sc.

Miriam Fischer, B.A.

Publications of our team members (selection)

  • Fischer C, Esser M. Strategien zur Verbesserung der Adhärenz. Pharma Relations 2020; 6(19):19-22
  • Esser M, Krischok K. Patientenzentrierung durch Partnering mit Patienten Pharma Relations 2019; 8(19):10-12
  • Esser M, Boreham A. Patient Journeys im Pharmamarketing. Patient Relations 2019;3(19):14-15
  • Esser M, Schreier J, Thaa B. Gesundheitsbezogene Lebensqualität in der frühen Nutzenbewertung: Stellenwert, Evidenznachweis und Auswertung aktueller Verfahren. Pharmazeutische Medizin 2018;20(2):68-75
  • Esser M, Schreier J, Thaa B. Lebensqualität in der frühen Nutzenbewertung. Market Access & Health Policy 2017; 7(5):26-28
  • Esser M, Schreier J. Visuelle Nutzenkommunikation. Market Access & Health Policy 2017; 7(1):28-29
  • Esser M. Placebo- und Nocebokommunikation in der Ästhetischen Chirurgie. Journal für Ästhetische Chirurgie 2016; 9(2):74-76
  • Esser M. Storytelling: Mehrdimensionale Inhalte statt eindimensionale Werbung. PM-Report 2016; 35(4):18-19
  • Esser M, Guyomard C. Patientenkommunikation: Wie Pharmaunternehmen Patienten erreichen. Patient Relations 2015; 15(7):20-21
  • Esser M, Umbach G. Die Planung der Klinikkommunikation mit dem Vierstufenmodell. Management & Krankenhaus 2014; 33(3):6
  • Schreier J, Esser M, Umbach G. Organisation von Advisory Board Meeting und Expertenrunden: Erfolgreich mit der 7-Punkte-Methode. Pharma Relations 2014; 14(12):17
  • Esser M, Guyomard C. Bessere Patientenführung durch gezielten Einsatz von Nozebo- und Plazebokommunikation. Frauenarzt 2013; 54(1):58-59
  • Guyomard C, Esser M. Nozebo- und Plazeboeffekt – Nutzen für die Kommunikation mit Diabetespatienten. Der Diabetologe 2013; 9(5):356-358
  • Esser M, Lang S. Brand Language: Worte mit Wirkung. PM-Report 2013; 1(32):18-20
  • Guyomard C, Esser M. Patientenkommunikaton zwischen Nozebo- und Placeboeffekt. Der Pneumologe 2013; 10(2):134-136
  • Esser M, Lang S. Patientenansprache mit Empathie. Arzneimittelzeitung 2012; 23(7): 20
  • Esser M, Umbach G. Patienteninformation in Zeiten von Informationsinfarkt und Cyberchondrie. PM-Report 2012; 31(10):14-16
  • Esser M, Lang S. Improving patient communication by writing with Empathy. Medical Writing 2012; 21(4): 305-307
  • Esser M, Fuß H. Mobiles Healthcaremarketing: 10 entscheidende Punkte für Konzeption und Umsetzung. Healthcare Marketing 2011; 10(8):64-66
  • Esser M, Riehn J. Storytelling für Healthcare als neuer Trend: Wie Sie die Geschichte Ihres Produkts erzählen und damit Markenbindung aufbauen. PM-eReport 2011; 1(1):1-4
  • Esser M. Medical Education für Patienten: Ein Update. PM-Report 2010; 7(29):18-19
  • Esser M, Lang S. Texte in der Pharmakommunikation. Healthcare Marketing 2010; 7(7):28-30
  • Lang S, Esser M. Writing in science and marketing – Are they really separate worlds? The Write Stuff 2010; 19(3):178-179
  • Esser M, Gianni G. Medical Education auch für Patienten. Healthcare Marketing 2009; Sonderdruck aus 4(6):2-4
  • Esser M. Medical Education: Markttrends und Erfolgsfaktoren. Arzneimittelzeitung 2009; 22(1):9

Closer to the patient –
What is important to us

Improving patient care

Innovative medicinal products and new medical devices only improve patient care if patients use them correctly. This is why co.patient has developed effective strategies and tools that increase patients' understanding of and adherence to therapy – to improve patient care.

Closer cooperation between industry and patients

Patients and industry are both eager to improve patient care. It is therefore only logical to also cooperate directly with one another in order to achieve these goals. co.patient sees itself as a mediator that brings industry and patients together – to enable beneficial cooperations.

Full transparency

Our clients should be able to fully trust us. We believe in clear communication and complete transparency, from our quote and the first step of the project right up to the feedback after project completion – to ensure that you have a complete understanding of what we do at all times.

Maximum benefit for clients

As a service provider our long-term existence depends on the value of our services for our clients. We work agile, service oriented and in line with your processes – to achieve the best possible results for you as a client.


Industry collaborations with HCPs and patients is a challenging venture due to many regulations such as ethical rules, transparency codes or drug acts. We have the required knowledge and necessary awareness to adhere to all the relevant regulations – to ensure that our clients are always on the safe side.


We have built a culture where differences in gender, ethnic background, religion and sexual orientation are respected. With diverse teams working together, we increase creativity and innovation – to achieve added value for our clients.


We care about our environment, work paperless and encourage remote work as not having to commute to work reduces gasoline consumption and energy – to minimize our carbon footprint.